Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
Post
-
-
GE HealthCare secures FDA 510(k) clearance for diagnostic viewer
GE HealthCare has received 510(k) clearance from the US Food and Drug Administration (FDA) for View, the diagnostic viewer within …
-
AbbVie reports topline data from Phase I ABBV-295 trial
AbbVie has reported positive top line data from the multiple ascending dose (MAD) section of its Phase I trial of …
-
NewcelX and Eledon partner for NCEL-101 programme
NewcelX has signed a collaborative research agreement with Eledon Pharmaceuticals to advance its NCEL-101 programme for type 1 diabetes (T1D). The …
-
LifeVac receives FDA De Novo classification for anti-choking device
LifeVac has received De Novo classification from the US Food and Drug Administration (FDA) for its suction anti-choking device under …
-
Aisa Pharma reports positive results for AISA-021
Aisa Pharma has reported positive results from its Phase II RECONNOITER trial of AISA-021 (cilnidipine), a once-daily calcium channel blocker, …
-
Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
-
BMS gains FDA approval for Sotyktu in psoriatic arthritis treatment
Bristol Myers Squibb (BMS) has received the US Food and Drug Administration (FDA) approval for Sotyktu (deucravacitinib), an oral selective …
-
Cognita secures FDA breakthrough device designation for CXR
Cognita has received the US Food and Drug Administration (FDA) breakthrough device designation for the Chest X-Ray (CXR) model across …
-
Seqster unveils 1-Click DataLake for clinical trials
Seqster has launched 1-Click DataLake, a real-world data platform to expedite trial design, recruitment, and evidence generation for healthcare and …
-
Liberate Bio gains licences for myeloid-specific CAR design patents
Liberate Bio has obtained both exclusive and non-exclusive licences for patents related to chimeric antigen receptor (CAR) designs tailored for …
-
Philips launches Rembra CT system for acute imaging
Philips has unveiled its next-generation radiology computed tomography (CT) system, Rembra, to address the challenges faced by acute and high-demand …
-
HUTCHMED begins Phase I/IIa trial of HMPL-A580 for solid tumours
HUTCHMED has commenced a Phase I/IIa clinical trial of its second antibody-targeted therapy conjugate (ATTC), HMPL-A580, targeting patients with unresectable, …
-
Affinia receives FDA fast track designation for AFTX-201
Affinia Therapeutics has received the US Food and Drug Administration (FDA) fast track designation (FTD) for AFTX-201, a genetic medicine …
-
Droplet improves genomic analysis speed using NVIDIA Parabricks software
Droplet Biosciences has reported a reduction in genomic analysis turnaround time for residual cancer detection by adopting graphics processing unit …
-
Kyowa Kirin discontinues ongoing trials of rocatinlimab
Kyowa Kirin has announced the global discontinuation of all ongoing clinical trials for rocatinlimab, an anti-OX40 monoclonal antibody under investigation …
-
Esperion to acquire Corstasis for cardiovascular franchise expansion
Esperion Therapeutics has signed a definitive agreement to acquire Corstasis Therapeutics to expand its cardiovascular franchise with the addition of …
